LIVER

Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan

H-Y Hsu¹, M-H Chang², Y-H Ni², H-L Chen¹

¹ Department of Paediatrics, National Taiwan University Hospital, Taipei, Taiwan, and Department of Primary Care Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
² Department of Paediatrics, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan

Correspondence to:
Correspondence to:
Dr M-H Chang
Department of Paediatrics, National Taiwan University Hospital, No 7, Chung-Shan South Rd, Taipei, Taiwan; mhchang{at}ha.mc.ntu.edu.tw

Background: It is not known whether hepatitis B virus (HBV) with mutations in the a determinant (amino acids (aa) 121–149) of the hepatitis B surface antigen (HBsAg) affect vaccination efficacy.

Aim: To investigate the prevalence and clinical significance of these mutants in children, 15 years after universal vaccination in Taiwan.

Methods: Nucleotide sequences encoding the a determinant region (aa 110–160) of HBsAg were analysed in all HBV-DNA positive sera from 1357 children and 219 adolescents serosurveyed in 1999. We then compared the prevalence and changes in the mutants in these children with our previous surveys in the same area conducted in 1984 (just before vaccination), 1989, and 1994.

Results: The prevalence of a determinant mutants in HBV-DNA positive children was 7.8% (8/103) in 1984, which significantly increased to 19.6% (10/51) in 1989, peaked at 28.1% (9/32) in 1994, and remained at 23.1% ((3/13) (T131I, G145R, G145R)) in 1999; it was higher in those fully vaccinated compared with those not vaccinated (15/46 v 15/153; p<0.001). However, the number of mutant infected children in each survey was stable in the first 5–10 year period but decreased 10–15 years post vaccination. Increased amino acid variation in the a determinant region occurred in carrier children in the post vaccination survey. Mutated residues tended to occur more frequently in the region with greater local hydrophilicity (residues 140–149) in those vaccinated than in unvaccinated children with variant infection (12/15 v 6/15; p = 0.062). More HBsAg positive a determinant mutants emerged in children fully vaccinated with plasma derived vaccine than those given recombinant vaccine (10/2399 (0.46%) v 0/503; p = 0.122).

Conclusion: We found that a determinant variants have an advantage in infecting immunised children but do not threaten current HBV vaccination strategies in Taiwan.

Abbreviations: aa, amino acids; HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen; anti-HBs, antibody to hepatitis B surface antigen; HBeAg, hepatitis B e antigen; anti-HBe, antibody to hepatitis B e antigen; anti-HBc, antibody to hepatitis B core antigen

Keywords: mutants; hepatitis B virus; hepatitis B surface antigen; children; vaccination

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Digest

Robin Spiller
Gut 2004 53: 1391. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Kirk, G. D., Bah, E., Montesano, R. (2006). Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis 27: 2070-2082 [Abstract] [Full Text]  
• Tran, N., Berne, R., Chann, R., Gauthier, M., Martin, D., Armand, M.-A., Ollivet, A., Teo, C. G., Ijaz, S., Flichman, D., Brunetto, M., Bielawski, K. P., Pichoud, C., Zoulim, F., Vernet, G. (2006). European multicenter evaluation of high-density DNA probe arrays for detection of hepatitis B virus resistance mutations and identification of genotypes.. J. Clin. Microbiol. 44: 2792-2800 [Abstract] [Full Text]  
• Ly, T. D., Servant-Delmas, A., Bagot, S., Gonzalo, S., Ferey, M.-P., Ebel, A., Dussaix, E., Laperche, S., Roque-Afonso, A.-M. (2006). Sensitivities of Four New Commercial Hepatitis B Virus Surface Antigen (HBsAg) Assays in Detection of HBsAg Mutant Forms.. J. Clin. Microbiol. 44: 2321-2326 [Abstract] [Full Text]  
• Lada, O., Benhamou, Y., Poynard, T., Thibault, V. (2006). Coexistence of Hepatitis B Surface Antigen (HBs Ag) and Anti-HBs Antibodies in Chronic Hepatitis B Virus Carriers: Influence of "a" Determinant Variants. J. Virol. 80: 2968-2975 [Abstract] [Full Text]